NIRAXX Trademark

Trademark Overview

On Monday, June 5, 2017, a trademark application was filed for NIRAXX with the United States Patent and Trademark Office. The USPTO has given the NIRAXX trademark a serial number of 87475995. The federal status of this trademark filing is REGISTERED as of Tuesday, June 19, 2018. This trademark is owned by NIRAXX LIGHT THERAPEUTICS INC.. The NIRAXX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Photobiomodulation therapy, namely, therapy involving light energy for skin conditions, pain, blood circulation; low level laser therapy, using special wavelength of light to treat depression, anxiety, sexual dysfunctions, down syndrome, alzheimer's disease, somatic pain, vagina infection, vaginal atrophy and fat reduction
niraxx

General Information

Serial Number87475995
Word MarkNIRAXX
Filing DateMonday, June 5, 2017
Status700 - REGISTERED
Status DateTuesday, June 19, 2018
Registration Number5499272
Registration DateTuesday, June 19, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements

Goods and ServicesPhotobiomodulation therapy, namely, therapy involving light energy for skin conditions, pain, blood circulation; low level laser therapy, using special wavelength of light to treat depression, anxiety, sexual dysfunctions, down syndrome, alzheimer's disease, somatic pain, vagina infection, vaginal atrophy and fat reduction

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 12, 2017
Primary Code044
First Use Anywhere DateTuesday, November 1, 2016
First Use In Commerce DateTuesday, August 8, 2017

Trademark Owner History

Party NameNIRAXX LIGHT THERAPEUTICS INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92617
Party NameNIRAXX LIGHT THERAPEUTICS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92617
Party NameNIRAXX LIGHT THERAPEUTICS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92617

Trademark Events

Event DateEvent Description
Monday, June 19, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 19, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, May 16, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 15, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 15, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, April 23, 2018USE AMENDMENT FILED
Monday, May 14, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 23, 2018TEAS STATEMENT OF USE RECEIVED
Friday, February 9, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 9, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 8, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 6, 2017EXAMINER'S AMENDMENT ENTERED
Monday, November 6, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2017EXAMINERS AMENDMENT E-MAILED
Monday, November 6, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, November 6, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, October 10, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, September 26, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 25, 2017ASSIGNED TO LIE
Sunday, September 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 9, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 8, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 4, 2017NON-FINAL ACTION E-MAILED
Monday, September 4, 2017NON-FINAL ACTION WRITTEN
Sunday, September 3, 2017ASSIGNED TO EXAMINER
Monday, June 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 8, 2017NEW APPLICATION ENTERED

Related Keywords

niraxx therapy light pain syndrome alzheimer down dysfunctions anxiety sexual disease